Compare Wahed FTSE USA Shariah ETF (HLAL) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wahed FTSE USA Shariah ETF vs Twist Bioscience Corp — how do they compare? Wahed FTSE USA Shariah ETF trades at $72.96, while Twist Bioscience Corp trades at $123.83 (market cap $7.72B). Which is the better fit depends on your goals.
| HLAL | TWST | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $73.60 | $124.88 |
52-Week Low | $55.52 | $24.16 |
Market Cap | — | $7.72B |
Enterprise Value | — | $7.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HLAL trades at $72.95, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bullish trend based on moving averages, though oscillators are neutral. The stock lacks recent fundamental data, with key ratios like P/E and P/S unavailable. A small dividend of $0.02 is scheduled for June 2026, but no recent earnings or cash flow updates are present.
The outlook is mixed due to incomplete financials; technical strength suggests potential upside, but fundamental opacity poses risks. Investors face uncertainty without current revenue or profit metrics, requiring caution until updated SEC filings or analyst reports emerge to assess valuation and growth prospects accurately.
Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.
The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Wahed FTSE USA Shariah ETF
HLAL is an ETF that invests in Shariah-compliant US companies. It follows a rigorous screening process to exclude businesses involved in non-compliant activities like interest-based finance, alcohol, and gambling.
Read more on HLAL →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
